Tori Whitacre Martonicz, MA

Tori Whitacre, editor of Infection Control Today, writer for over 30 years.

Tori Whitacre Martonicz, MA, is the lead editor of Infection Control Today. She has been a writer and editor for over 30 years and has an MA and BA in English Composition/Literature from the University of Akron in Akron, OH. She lives in Ohio with her husband, Eric; son, Drake; 2 tiny dogs, Selena Brigid Sophia and Doctor Danger Dog; and a big black cat, Freya. She loves reading, writing, gardening, and spending time with her loved ones.

Contact her through her email: tmartonicz@mjhlifesciences.com.

Articles by Tori Whitacre Martonicz, MA

Surgical instruments being sterilized  (Adobe Stock 325838636 by Senalfred)

A new human factors study reveals the hidden complexity behind sterile processing. Research from the Medical University of South Carolina shows how sterile processing, operating rooms, and courier networks function as one interconnected system. Understanding “work as done” rather than “work as imagined” may be key to improving surgical safety and supporting frontline staff.

Dental Assistant Recognition Week (Adobe Stock 740030692 by Neelrong)

Dental Assistants Recognition Week spotlights the critical role dental assistants play in infection prevention, patient safety, and instrument sterilization. From PPE adherence to surface disinfection and patient education, these professionals manage complex clinical and administrative tasks that protect both patients and dental teams in high-risk aerosol-generating environments. (Entire interview)

Infection prevention leaders share final takeaways on stethoscope hygiene and health care-associated infection prevention. From touch-free diaphragm barriers to accountability and culture change, the message is clear: We cannot “wash our way out” of contamination. Protecting immunocompromised and high-risk patients requires consistent, practical, barrier-based solutions at the bedside.

Infection prevention experts weigh in: What’s overhyped in stethoscope hygiene? Disposable scopes. What’s underrated? Real-time auditing, education, and barriers that prevent contamination. What’s non-negotiable? Accountability and a commitment to “do no harm.” Preventing health care-associated infections (HAIs) requires policy and demands practical, measurable action at the bedside.

Can leadership unintentionally sabotage infection prevention efforts? Experts say yes. Top-down mandates, lack of recognition, and checkbox adherence weaken real change. Sustainable infection prevention and control (IPC) requires collaboration, visibility, frontline input, and measurable monitoring. When leaders partner instead of dictate, adherence improves and IPC becomes culture, not paperwork.

Why do infection prevention policies fail? Experts say it’s rarely about knowledge and often about workflow. If protocols are complex, inconvenient, or lack end-user input, adherence drops. Simplicity, repetition, leadership support, and frontline engagement are what turn policy into sustained practice change in real clinical settings.

How do you prove stethoscope barriers reduce infections? Experts say tracking usage data, unit comparisons, contamination trends, and outbreak rates is key. Like hand hygiene monitoring, measurable adherence and outcome metrics determine real infection prevention and control value. Without monitoring and leadership follow-up, policy alone won’t drive meaningful change.

Infection prevention leaders weigh whether stethoscope barrier use should become formal policy. Success hinges on workflow integration, accessibility, infrastructure support, and shared accountability. Without proper placement, maintenance, and staff buy-in, even strong policies risk failure. Experts say convenience and operational planning determine whether adherence becomes reality.

Clinicians debate acoustic performance, cost, and compliance in stethoscope hygiene. Data show touch-free diaphragm barriers maintain sound quality while reducing contamination risk, unlike disposable stethoscopes, which may compromise diagnosis. Experts highlight workflow fit, proper placement, and eliminating misuse as keys to improving infection prevention in high-risk settings.

Experts discuss how touch-free stethoscope diaphragm barriers offer aseptic protection at the point of care. Unlike wipes, barriers prevent contamination rather than partially reducing it. Success depends on workflow integration, strategic placement, and hand hygiene alignment, making infection prevention practical in emergency departments, intensive care units, operating rooms, and outpatient settings.

After multiple central line infections, intensive care unit (ICU) leaders examined stethoscope hygiene and found major compliance gaps. Plastic sleeves failed, but diaphragm covers integrated into a bundled prevention strategy led to significant infection reduction. Their results, presented at NTI 2025 and forthcoming in Critical Care Nurse, highlight practical, point-of-care solutions.

New infection prevention technologies only work if staff and leadership truly adopt them. Experts highlight education, workflow alignment, leadership support, financial framing, and small measurable changes as keys to lasting implementation. Without buy-in and practical integration, even clinically validated tools risk becoming just another unused policy add-on.

Infection prevention experts warn that stethoscope hygiene remains inconsistent across emergency departments and high-volume outpatient settings. Research shows cleaning reduces bioburden but does not eliminate pathogens. Leaders argue stethoscopes should be treated like hands, with stronger accountability, barriers, and workflow-driven solutions to reduce health care-associated infection risk.

Infection prevention leaders discuss why stethoscope hygiene continues to “fall through the cracks” in health care settings. From emergency departments to outpatient care, experts warn that inconsistent cleaning makes stethoscopes a persistent source of health care-associated infection (HAI) risk and call for practical, evidence-based solutions.

A series of illustrations demonstrating the body’s immune response to sepsis (Adobe Stock 805248810 by Tee with AI)

A multicenter randomized trial of 276 patients with sepsis found that precision immunotherapy targeting immune dysfunction improved organ failure scores by day 9 compared with placebo. Although mortality differences were not statistically significant, the results suggest that biomarker-guided treatment strategies could help personalize sepsis care and improve clinical outcomes.

Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, the 2025 APIC President

As her 2025 APIC presidency concludes, Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, discusses public health funding cuts, science advocacy, global partnerships, workforce development, and why infection preventionists must speak up. In this exclusive ICT interview, she shares lessons from a tumultuous year and her vision for strengthening the infection prevention profession worldwide.

Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, the 2025 APIC President

As her 2025 APIC presidency concludes, Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, discusses public health funding cuts, science advocacy, global partnerships, workforce development, and why infection preventionists must speak up. In this exclusive ICT interview, she shares lessons from a tumultuous year and her vision for strengthening the infection prevention profession worldwide.

Scientific microscope for using in R&D  (Adobe Stock 526445021 by chokniti)

Before a disinfectant reaches a hospital unit, it undergoes rigorous laboratory testing, formulation science, and regulatory validation. In this ICT Q&A, Candice Taylor, MA, explains how R&D bridges lab efficacy with real-world health care workflow, antimicrobial resistance concerns, and the evolving future of infection prevention technology.

Survey special blue banner background  (Adobe Stock 216473756By FR Design)

Infection prevention professionals are weighing in on the CDC’s updated vaccine schedule. An ICT survey reveals mixed familiarity, rising patient questions, and a strong call for clearer guidance and communication tools. Here’s what IPC leaders say about implementation, confidence, and the real-world impact of vaccine policy changes.